精子库市场－2026-2031年预测

预计精子库市场将从 2025 年的 48.02 亿美元成长到 2031 年的 62.33 亿美元，复合年增长率为 4.44%。

精子库市场是辅助生殖技术（ART）和生殖医学产业内的一个专业领域，专注于捐精的取得、冷冻保存、品质保证和分发。这些营业单位是生育诊所和直接消费者的重要精子供应来源，使面临男性不孕症的个人和夫妇、单身女性以及女同性恋伴侣能够建立家庭。

核心服务职能与临床角色

精子库作为受严格监管的生物样本库和服务供应商运作。其核心业务包括严格的捐精者招募和筛检（包括医学、遗传和心理评估）、精液处理和冷冻保存、全面的传染病检查以及安全的长期储存。精子库提供详细的捐精者信息，并协助将检体匹配并运送至获得许可的医疗机构或直接运送至消费者，用于宫腔内人工授精（IUI）和体外受精（IVF）等手术。精子库的功能是满足第三方辅助生殖的基本生物学需求，并确保安全、可靠且符合伦理规范地供应生殖细胞。

主要市场成长要素

市场扩张的根本驱动因素是全球不孕症发病率的上升以及人们对男性因素影响的认识不断提高。环境、生活方式和肥胖等因素导致的精子参数下降，使得需要捐精的患者群体不断扩大。同时，晚婚趋势（可能影响男性和女性的生育能力）也进一步推动了不孕症治疗服务（包括捐精）的需求。

重要的社会人口结构变化正在重塑和扩大消费群。社会对多元化家庭结构的接受度不断提高，法律授权，包括选择单身的女性和女同性恋伴侣，这催生了一个庞大而独特的需求群体，他们几乎完全依赖捐精来实现受孕。这种人口结构的变化正在将市场拓展到传统上以面临严重男性不孕症的异性恋夫妇为主导的领域之外。

肥胖症的增加是一个特定的生理因素，因为它与男性荷尔蒙失衡和精液品质差有关，这间接地支持了市场需求，扩大了寻求不孕症检测和捐精解决方案的人群范围。

相关诊断和辅助生殖技术的进步也推动了市场的发展。精液分析技术的改进以及临床上对男性不孕症评估的日益重视，导致需要使用捐精的病例数量不断增加。此外，体外受精（IVF）和人工授精（IUI）等辅助生殖技术（ART）的广泛应用和成功，为捐精的利用提供了一条重要的临床途径，从而产生了协同效应。

一些地区的政府支持政策（儘管各不相同）和不断完善的法规结构正在促进市场准入和合法性。政府资助生育治疗、建立公共配子库以及製定关于捐精和子女权利的明确法律准则，可以减少障碍，并鼓励在受监管的体系内推广使用。

主要服务业和消费者偏好

市场按服务类型细分，精液分析和储存服务是诊断和生育力保存的核心产品，但用于治疗目的的捐精分发构成了主要的收入来源。

消费者的偏好往往需要在成本和复杂性之间做出权衡。与体外受精（IVF）相比，使用捐精进行人工授精（IUI）由于成本相对较低且创伤性小，仍然是一种重要的促排卵方法，这推动了尝试这一一线治疗方案的个人和夫妇对捐精的需求。然而，体外受精的高成功率，尤其是在年龄较大的求子者和存在其他不孕因素的患者中，也使得对更复杂的治疗週期的需求保持强劲。

区域背景和监管成熟度

北美是一个成熟且重要的市场，其特点是拥有完善的商业和非营利精子库网络、对辅助生殖技术（ART）服务的高度认知和利用率，以及相对稳定的法规环境。众多全球性公司的存在和先进的临床基础设施巩固了其主导地位。

欧洲是一个重要且成熟的市场，拥有悠久的公共和私人精子库体系、完善的捐精者监管规定，并且在许多国家消费者都能便捷地获取精子。成熟的营运机构和细緻的捐精者资讯评估是该地区的优势所在。

亚太地区被公认为高成长市场，其成长动力主要来自大规模的人口基数、不断上升的不孕不育率、生殖健康服务医疗旅游的兴起以及人们对捐精受孕文化态度的逐渐转变。医疗保健体系的完善和国际精子库的进入正在加速市场发展。

竞争格局与策略演变

竞争格局包括拥有庞大捐精者名录和全球分销网络的国际大规模精子库，以及区域性专业精子库和诊所附属精子库。竞争的重点在于捐精者的多样性和资料深度、严格的品质和安全标准、客户服务（包括用于选择捐精者的线上平台）以及可靠的运输物流和地理覆盖。

策略性措施着重于扩大捐赠者招募范围，以满足不同种族和表型的需求；改进数位化介面，打造流畅的客户体验；以及应对复杂的国际进出口法规，开拓新市场。此外，投资基因筛检技术以确保产品质量，以及研究冷冻保存样本的长期储存潜力，也是重点关注领域。

未来市场趋势

精子库市场的未来发展趋势是朝着更个人化、基因透明化和全球可及性的方向发展。消费者需求正在转向更充分地揭露捐赠者的基因和健康资讯。将先进的基因筛检（例如，扩展的携带者筛检）纳入捐赠者评估流程将日益成为标准做法。

关于捐精者匿名、后代资讯揭露权和补偿模式的伦理辩论和不断变化的法规将持续影响市场格局。产业相关人员的成功取决于能否坚持最高的医疗和伦理标准，适应多元化的法律环境，并满足日益增长且更加多元化的全球客户群不断变化的期望。随着计划生育和家庭结构多元化的社会趋势持续发展，精子库市场预计将稳定成长，并成为现代生殖健康生态系统的重要组成部分。

本报告的主要优势：

• 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
• 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
• 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
• 可操作的建议：利用这些见解，在动态环境中製定策略决策，发展新的业务流和收入来源。
• 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

它是用来做什么的？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

• 2022年至2024年的历史数据和2025年至2031年的预测数据
• 成长机会、挑战、供应链前景、法规结构与趋势分析
• 竞争定位、策略和市场占有率分析
• 按业务板块和地区（包括国家）分類的收入和预测评估
• 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章 引言

• 市场概览
• 市场定义
• 调查范围
• 市场区隔
• 货币
• 先决条件
• 基准年和预测年时间表

第二章调查方法

• 调查数据
• 先决条件

第三章执行摘要

• 调查亮点

第四章 市场动态

• 市场驱动因素
• 市场限制
• 波特五力分析
• 产业价值链分析

5. 按捐赠者类型分類的精子库市场

• 介绍
• 熟人捐赠者
• 匿名捐赠者

6. 按服务分類的精子库市场

• 介绍
• 精子储存
• 精液分析
• 遗传咨询

7. 依受精技术分類的精子库市场

• 介绍
• 供体人工授精
• 体外受精

8. 按地区分類的精子库市场

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列
  • 其他的
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 合併、收购、协议和合作
• 供应商竞争力矩阵

第十章：公司简介

• Xytex
• Fairfax Cryobank
• California Cryobank
• Cryos International
• Seattle Sperm Bank
• Johns Hopkins Medicine
• Apollo Fertility
• Indira IVF
• Birla Fertility and IVF

Sperm Bank Market is projected to grow at a 4.44% CAGR, reaching USD 6.233 billion in 2031 from USD 4.802 billion in 2025.

The sperm bank market is a specialized segment within the broader assisted reproductive technology (ART) and reproductive health industry, focused on the procurement, cryopreservation, quality assurance, and distribution of donor sperm. These entities function as critical suppliers to fertility clinics and direct consumers, enabling family building for individuals and couples facing male factor infertility, single women, and same-sex female couples.

Core Service Function and Clinical Role

Sperm banks operate as highly regulated biorepositories and service providers. Their core activities involve rigorous donor recruitment and screening (including medical, genetic, and psychological evaluations), semen processing and cryopreservation, extensive infectious disease testing, and secure long-term storage. They provide detailed donor profiles and facilitate the matching and shipment of specimens to licensed healthcare providers or directly to consumers for use in procedures such as intrauterine insemination (IUI) or in-vitro fertilization (IVF). Their role is to ensure a safe, reliable, and ethically managed supply of gametes, addressing a fundamental biological need in third-party reproduction.

Primary Market Growth Drivers

Market expansion is fundamentally driven by the rising global prevalence of infertility, with increasing acknowledgment of male factor contributors. Declining sperm parameters linked to environmental, lifestyle, and obesity-related factors are expanding the patient population requiring donor gametes. Concurrently, the trend toward delayed parenthood, which can impact both male and female fertility, further elevates the utilization of fertility services, including those involving donor sperm.

Significant sociodemographic shifts are reshaping and broadening the consumer base. The growing social acceptance and legal recognition of diverse family structures-including single women by choice and lesbian couples-has created substantial, dedicated demand segments that rely almost exclusively on donor sperm to achieve pregnancy. This demographic evolution has moved the market beyond its traditional base of heterosexual couples facing severe male infertility.

The increasing prevalence of obesity represents a specific physiological driver, as it is associated with hormonal imbalances and reduced semen quality in men. This contributes to the pool of individuals seeking fertility evaluation and potentially donor solutions, thereby indirectly supporting market demand.

Advancements in related diagnostic and reproductive technologies also stimulate the market. Improved semen analysis techniques and a greater clinical focus on male fertility assessment lead to more diagnoses of conditions necessitating donor sperm. Furthermore, the growth and success of ART procedures like IVF and IUI provide the essential clinical pathways through which donor sperm is utilized, creating a synergistic relationship.

Supportive, though varied, government initiatives and evolving regulatory frameworks in some regions are facilitating market access and legitimacy. Public funding for fertility treatments, the establishment of public gamete banks, and clear legal guidelines for donor conception and offspring rights can reduce barriers and encourage utilization within regulated systems.

Key Service Segments and Consumer Preferences

The market is segmented by service type, with semen analysis and storage services representing a core offering for diagnostic and fertility preservation purposes. However, the distribution of donor sperm for therapeutic use constitutes the primary revenue stream.

Consumer preference often involves a trade-off between cost and complexity. Donor insemination (IUI) remains a significant entry point due to its relatively lower cost and less invasive nature compared to IVF, driving demand for donor sperm from individuals and couples attempting this first-line treatment. However, the higher success rates of IVF, particularly for older recipients or those with additional fertility factors, also sustain strong demand within more complex treatment cycles.

Geographic Landscape and Regulatory Maturity

North America represents a mature and dominant market, characterized by a well-established network of commercial and non-profit banks, high awareness and utilization of ART services, and a relatively stable regulatory environment. The presence of major global market players and advanced clinical infrastructure consolidates its leadership.

Europe is a significant and sophisticated market, with a strong tradition of both public and private banking systems, comprehensive donor regulation, and high levels of consumer access in many countries. The region benefits from established players and a culture of detailed donor profiling.

The Asia-Pacific region is identified as a high-growth market, fueled by large populations, rising infertility rates, increasing medical tourism for reproductive services, and gradual shifts in cultural attitudes toward donor conception. Improving healthcare systems and the entry of international banks are accelerating market development.

Competitive Landscape and Strategic Evolution

The competitive environment includes large international cryobanks with extensive donor catalogues and global distribution networks, regional specialists, and clinic-affiliated banks. Competition centers on donor diversity and profile depth, rigorous quality and safety standards, customer service (including online platforms for donor selection), and geographic reach through reliable shipping logistics.

Strategic initiatives focus on expanding donor recruitment to meet diverse ethnic and phenotypic demands, enhancing digital interfaces for a seamless client experience, and navigating complex international import/export regulations to access new markets. Investments in genetic screening technologies and long-term viability studies of cryopreserved samples are also key areas of focus to ensure product quality.

Future Market Trajectory

The future trajectory of the sperm bank market is oriented toward greater personalization, genetic transparency, and global accessibility. Consumer demand is shifting toward more extensive donor genetic and health information. The integration of advanced genetic screening (e.g., expanded carrier screening) into donor evaluation will become increasingly standard.

The market will continue to be shaped by ethical debates and regulatory evolution concerning donor anonymity, offspring rights to information, and compensation models. Success for industry participants will depend on maintaining the highest standards of medical and ethical practice, adapting to diverse legal landscapes, and meeting the evolving expectations of a more informed and diverse global clientele. As societal trends toward planned parenthood and diverse family formation persist, the sperm bank market is poised for steady growth, serving as an essential component in the ecosystem of modern reproductive medicine.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Sperm Bank Market Segmentation:

• By Donor Type
• Known Donor
• Anonymous Donor
• By Service
• Sperm Storage
• Semen Analysis
• Genetic Consultation
• By Fertilization Techniques
• Donor Insemination
• In Vitro Insemination
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. SPERM BANK MARKET, BY DONOR TYPE

• 5.1. Introduction
• 5.2. Known Donor
• 5.3. Anonymous Donor

6. SPERM BANK MARKET, BY SERVICE

• 6.1. Introduction
• 6.2. Sperm Storage
• 6.3. Semen Analysis
• 6.4. Genetic Consultation

7. SPERM BANK MARKET, BY FERTILIZATION TECHNIQUES

• 7.1. Introduction
• 7.2. Donor Insemination
• 7.3. In Vitro Insemination

8. SPERM BANK MARKET, BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. The Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

• 10.1. Xytex
• 10.2. Fairfax Cryobank
• 10.3. California Cryobank
• 10.4. Cryos International
• 10.5. Seattle Sperm Bank
• 10.6. Johns Hopkins Medicine
• 10.7. Apollo Fertility
• 10.8. Indira IVF
• 10.9. Birla Fertility and IVF